Effects of sodium-glucose co-transporter 2 inhibitor on metabolic parameters in patients with diabetes mellitus
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000021584
- Lead Sponsor
- agoya University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
None.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ipid-metabolic parameters: serum total cholesterol, HDL and LDL cholesterol, and triglyceride levels Hepatic function parameters: serum AST, ALT, and gamma-GTP levels Genital infection (female): intravaginal bacteria and fungi These parameters are compared before and 6 mo after the administration of SGLT2 inhibitor.
- Secondary Outcome Measures
Name Time Method Visceral fat area, basal metabolic rate, and serum insulin and adiponectin levels